{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T17:01:22Z","timestamp":1790096482001,"version":"4.0.1"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,12,16]],"date-time":"2022-12-16T00:00:00Z","timestamp":1671148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2022,12,16]],"date-time":"2022-12-16T00:00:00Z","timestamp":1671148800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"funder":[{"name":"Bayer Consumer Care AG"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ophthalmol Ther"],"published-print":{"date-parts":[[2023,2]]},"DOI":"10.1007\/s40123-022-00631-7","type":"journal-article","created":{"date-parts":[[2022,12,16]],"date-time":"2022-12-16T15:03:21Z","timestamp":1671203001000},"page":"561-575","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["The Patient Voice in Neovascular Age-Related Macular Degeneration: Findings from a Qualitative Study"],"prefix":"10.1007","volume":"12","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6126-6476","authenticated-orcid":false,"given":"S. James","family":"Talks","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincent","family":"Daien","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Mitchell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tariq","family":"Aslam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jane","family":"Barratt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Biberger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ecosse L.","family":"Lamoureux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ceri","family":"Hirst","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michelle","family":"Sylvanowicz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert P.","family":"Finger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,12,16]]},"reference":[{"issue":"7","key":"631_CR1","doi-asserted-by":"publisher","first-page":"1259","DOI":"10.1007\/s00417-017-3647-4","volume":"255","author":"P Lanzetta","year":"2017","unstructured":"Lanzetta P, Loewenstein A, Vision Academy Steering Committee. Fundamental principles of an anti-VEGF treatment regimen: optimal application of intravitreal anti-vascular endothelial growth factor therapy of macular diseases. Graefes Arch Clin Exp Ophthalmol. 2017;255(7):1259\u201373.","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"issue":"12","key":"631_CR2","doi-asserted-by":"publisher","first-page":"1753","DOI":"10.1016\/j.ophtha.2017.05.035","volume":"124","author":"JM Colijn","year":"2017","unstructured":"Colijn JM, Buitendijk GHS, Prokofyeva E, et al. Prevalence of age-related macular degeneration in Europe: the past and the future. Ophthalmology. 2017;124(12):1753\u201363.","journal-title":"Ophthalmology"},{"key":"631_CR3","doi-asserted-by":"crossref","unstructured":"Bobadilla M, Pariente A, Oca AI, Pelaez R, Perez-Sala A, Larrayoz IM. Biomarkers as predictive factors of anti-VEGF response. Biomedicines. 2022;10(5):1003.","DOI":"10.3390\/biomedicines10051003"},{"key":"631_CR4","doi-asserted-by":"publisher","first-page":"2653","DOI":"10.2147\/DDDT.S295223","volume":"15","author":"RM Hussain","year":"2021","unstructured":"Hussain RM, Shaukat BA, Ciulla LM, Berrocal AM, Sridhar J. Vascular endothelial growth factor antagonists: promising players in the treatment of neovascular age-related macular degeneration. Drug Des Dev Ther. 2021;15:2653\u201365.","journal-title":"Drug Des Dev Ther"},{"issue":"9","key":"631_CR5","doi-asserted-by":"publisher","first-page":"1673","DOI":"10.1097\/IAE.0000000000002670","volume":"40","author":"FG Holz","year":"2020","unstructured":"Holz FG, Figueroa MS, Bandello F, et al. Ranibizumab treatment in treatment-naive neovascular age-related macular degeneration: results from LUMINOUS, a global real-world study. Retina. 2020;40(9):1673\u201385.","journal-title":"Retina"},{"issue":"12","key":"631_CR6","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0244183","volume":"15","author":"FG Holz","year":"2020","unstructured":"Holz FG, Minnella AM, Tuli R, et al. Ranibizumab treatment patterns in prior ranibizumab-treated neovascular age-related macular degeneration patients: real-world outcomes from the LUMINOUS study. PLoS ONE. 2020;15(12):e0244183.","journal-title":"PLoS ONE"},{"issue":"11","key":"631_CR7","doi-asserted-by":"publisher","first-page":"1582","DOI":"10.1038\/eye.2017.108","volume":"31","author":"H Almuhtaseb","year":"2017","unstructured":"Almuhtaseb H, Johnston RL, Talks JS, Lotery AJ. Second-year visual acuity outcomes of nAMD patients treated with aflibercept: data analysis from the UK Aflibercept Users Group. Eye (Lond). 2017;31(11):1582\u20138.","journal-title":"Eye (Lond)"},{"key":"631_CR8","doi-asserted-by":"publisher","DOI":"10.1007\/s00417-021-5073-8","author":"N Eter","year":"2021","unstructured":"Eter N, Hasanbasic Z, Keramas G, et al. PERSEUS 24-month analysis: a prospective non-interventional study to assess the effectiveness of intravitreal aflibercept in routine clinical practice in Germany in patients with neovascular age-related macular degeneration. Graefes Arch Clin ExpOphthalmol. 2021. https:\/\/doi.org\/10.1007\/s00417-021-5073-8.","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"631_CR9","doi-asserted-by":"publisher","first-page":"46453","DOI":"10.1038\/srep46453","volume":"7","author":"Y Zheng","year":"2017","unstructured":"Zheng Y, Wu X, Lin X, Lin H. The prevalence of depression and depressive symptoms among eye disease patients: a systematic review and meta-analysis. Sci Rep. 2017;7:46453.","journal-title":"Sci Rep"},{"key":"631_CR10","doi-asserted-by":"crossref","unstructured":"Jian-Yu E, Li T, McInally L, et al. Environmental and behavioural interventions for reducing physical activity limitation and preventing falls in older people with visual impairment. Cochrane Database Syst Rev. 2020;9:CD009233.","DOI":"10.1002\/14651858.CD009233.pub3"},{"key":"631_CR11","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1016\/j.ophtha.2020.07.060","volume":"128","author":"M Okada","year":"2020","unstructured":"Okada M, Mitchell P, Finger RP, et al. Non-adherence or non-persistence to intravitreal injection therapy for neovascular age-related macular degeneration: a mixed-methods systematic review. Ophthalmology. 2020;128:234\u201347.","journal-title":"Ophthalmology"},{"issue":"7","key":"631_CR12","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1001\/jamaophthalmol.2021.1660","volume":"139","author":"M Okada","year":"2021","unstructured":"Okada M, Wong TY, Mitchell P, et al. Defining nonadherence and nonpersistence to anti-vascular endothelial growth factor therapies in neovascular age-related aacular degeneration. JAMA Ophthalmol. 2021;139(7):769\u201376.","journal-title":"JAMA Ophthalmol"},{"key":"631_CR13","first-page":"55","volume":"10","author":"VR Cimarolli","year":"2016","unstructured":"Cimarolli VR, Casten RJ, Rovner BW, Heyl V, Sorensen S, Horowitz A. Anxiety and depression in patients with advanced macular degeneration: current perspectives. Clin Ophthalmol. 2016;10:55\u201363.","journal-title":"Clin Ophthalmol"},{"issue":"2","key":"631_CR14","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1016\/j.psc.2011.02.009","volume":"34","author":"M Park","year":"2011","unstructured":"Park M, Unutzer J. Geriatric depression in primary care. Psychiatr Clin North Am. 2011;34(2):469\u201387.","journal-title":"Psychiatr Clin North Am"},{"issue":"5","key":"631_CR15","doi-asserted-by":"publisher","first-page":"1281","DOI":"10.1007\/s00417-012-2177-3","volume":"251","author":"KM Droege","year":"2013","unstructured":"Droege KM, Muether PS, Hermann MM, et al. Adherence to ranibizumab treatment for neovascular age-related macular degeneration in real life. Graefes Arch Clin Exp Ophthalmol. 2013;251(5):1281\u20134.","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"issue":"4","key":"631_CR16","doi-asserted-by":"publisher","first-page":"205","DOI":"10.4274\/tjo.28003","volume":"47","author":"O Polat","year":"2017","unstructured":"Polat O, Inan S, Ozcan S, et al. Factors affecting compliance to intravitreal anti-vascular endothelial growth factor therapy in patients with age-related macular degeneration. Turk J Ophthalmol. 2017;47(4):205\u201310.","journal-title":"Turk J Ophthalmol"},{"issue":"8","key":"631_CR17","doi-asserted-by":"publisher","first-page":"1117","DOI":"10.1038\/eye.2017.49","volume":"31","author":"RK Jones","year":"2017","unstructured":"Jones RK, Jefferis JM. Is qualitative research under-represented in ophthalmology journals? Eye (Lond). 2017;31(8):1117\u20139.","journal-title":"Eye (Lond)"},{"issue":"7","key":"631_CR18","doi-asserted-by":"publisher","first-page":"1050","DOI":"10.1001\/archopht.119.7.1050","volume":"119","author":"CM Mangione","year":"2001","unstructured":"Mangione CM, Lee PP, Gutierrez PR, et al. Development of the 25-item National Eye Institute Visual Function Questionnaire. Arch Ophthalmol. 2001;119(7):1050\u20138.","journal-title":"Arch Ophthalmol"},{"issue":"12","key":"631_CR19","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0209218","volume":"13","author":"J Lane","year":"2018","unstructured":"Lane J, Rohan EMF, Sabeti F, et al. Impacts of impaired face perception on social interactions and quality of life in age-related macular degeneration: a qualitative study and new community resources. PLoS ONE. 2018;13(12):e0209218.","journal-title":"PLoS ONE"},{"issue":"3","key":"631_CR20","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1038\/s41433-019-0445-8","volume":"34","author":"DJ Taylor","year":"2020","unstructured":"Taylor DJ, Jones L, Binns AM, Crabb DP. \u201cYou\u2019ve got dry macular degeneration, end of story\u201d: a qualitative study into the experience of living with non-neovascular age-related macular degeneration. Eye (Lond). 2020;34(3):461\u201373.","journal-title":"Eye (Lond)"},{"issue":"3","key":"631_CR21","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1111\/nhs.12048","volume":"15","author":"M Vaismoradi","year":"2013","unstructured":"Vaismoradi M, Turunen H, Bondas T. Content analysis and thematic analysis: implications for conducting a qualitative descriptive study. Nurs Health Sci. 2013;15(3):398\u2013405.","journal-title":"Nurs Health Sci"},{"issue":"8","key":"631_CR22","doi-asserted-by":"publisher","first-page":"967","DOI":"10.1016\/j.jval.2011.06.014","volume":"14","author":"DL Patrick","year":"2011","unstructured":"Patrick DL, Burke LB, Gwaltney CJ, et al. Content validity-establishing and reporting the evidence in newly developed patient-reported outcomes (PRO) instruments for medical product evaluation: ISPOR PRO good research practices task force report: part 1\u2013eliciting concepts for a new PRO instrument. Value Health. 2011;14(8):967\u201377.","journal-title":"Value Health"},{"issue":"2","key":"631_CR23","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1191\/1478088706qp063oa","volume":"3","author":"V Braun","year":"2006","unstructured":"Braun V, Clarke V. Using thematic analysis in psychology. Qual Res Psych. 2006;3(2):77\u2013101.","journal-title":"Qual Res Psych"},{"issue":"3","key":"631_CR24","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1080\/13548506.2014.936886","volume":"20","author":"J Boyle","year":"2015","unstructured":"Boyle J, Vukicevic M, Koklanis K, Itsiopoulos C. Experiences of patients undergoing anti-VEGF treatment for neovascular age-related macular degeneration: a systematic review. Psychol Health Med. 2015;20(3):296\u2013310.","journal-title":"Psychol Health Med"},{"key":"631_CR25","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1016\/j.ajo.2017.03.005","volume":"177","author":"H Senra","year":"2017","unstructured":"Senra H, Balaskas K, Mahmoodi N, Aslam T. Experience of anti-VEGF treatment and clinical levels of depression and anxiety in patients with wet age-related macular degeneration. Am J Ophthalmol. 2017;177:213\u201324.","journal-title":"Am J Ophthalmol"},{"issue":"1","key":"631_CR26","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1186\/s12886-020-01554-2","volume":"20","author":"RP Finger","year":"2020","unstructured":"Finger RP, Daien V, Eldem BM, et al. Anti-vascular endothelial growth factor in neovascular age-related macular degeneration\u2014a systematic review of the impact of anti-VEGF on patient outcomes and healthcare systems. BMC Ophthalmol. 2020;20(1):294.","journal-title":"BMC Ophthalmol"},{"issue":"5","key":"631_CR27","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1080\/09638288.2020.1775901","volume":"44","author":"A Thier","year":"2022","unstructured":"Thier A, Holmberg C. The patients\u2019 view: age-related macular degeneration and its effects\u2014a meta-synthesis. Disabil Rehabil. 2022;44(5):661\u201371.","journal-title":"Disabil Rehabil"},{"issue":"6","key":"631_CR28","doi-asserted-by":"publisher","first-page":"976","DOI":"10.1016\/j.socscimed.2012.04.023","volume":"75","author":"AE Bennion","year":"2012","unstructured":"Bennion AE, Shaw RL, Gibson JM. What do we know about the experience of age related macular degeneration? A systematic review and meta-synthesis of qualitative research. Soc Sci Med. 2012;75(6):976\u201385.","journal-title":"Soc Sci Med"},{"issue":"12","key":"631_CR29","doi-asserted-by":"publisher","first-page":"1561","DOI":"10.1038\/eye.2015.167","volume":"29","author":"C McCloud","year":"2015","unstructured":"McCloud C, Lake S. Understanding the patient\u2019s lived experience of neovascular age-related macular degeneration: a qualitative study. Eye. 2015;29(12):1561\u20139.","journal-title":"Eye"},{"issue":"1","key":"631_CR30","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1038\/s41433-021-01470-9","volume":"36","author":"E Midena","year":"2022","unstructured":"Midena E, Varano M, Pilotto E, et al. Real-life patient journey in neovascular age-related macular degeneration: a narrative medicine analysis in the Italian setting. Eye (Lond). 2022;36(1):182\u201392.","journal-title":"Eye (Lond)"}],"container-title":["Ophthalmology and Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40123-022-00631-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40123-022-00631-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40123-022-00631-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,11]],"date-time":"2023-01-11T17:19:00Z","timestamp":1673457540000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40123-022-00631-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12,16]]},"references-count":30,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2023,2]]}},"alternative-id":["631"],"URL":"https:\/\/doi.org\/10.1007\/s40123-022-00631-7","relation":{},"ISSN":["2193-8245","2193-6528"],"issn-type":[{"value":"2193-8245","type":"print"},{"value":"2193-6528","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,12,16]]},"assertion":[{"value":"27 October 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 December 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 December 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}